Yamaha Corporation

In individual announcements released on the 26th, ABEJA resolved to establish a wholly-owned subsidiary in Singapore. Globing plans a significant profit increase and higher dividend for the fiscal year ending May 2027 (IFRS). Susmed's exclusive sales contract with Shionogi for its insomnia disorder app has ended. Nexera received a milestone payment of approximately 1.591 billion yen related to its partner Neurocrine's Phase 2 trial for cognitive impairment in Alzheimer's disease. Kasumigaseki Capital sold a property held for sale (Miami development land) for its first U.S. project, and Yamaha announced the partial sale of its shares in Yamaha Motor. Matsui Securities set its interim dividend for the fiscal year ending March 2027 at 28 yen (compared to 25 yen in the same period last year), and Medical Net resolved the material weakness in internal control over financial reporting that had been disclosed.

Fender has sent a notice to Yamaha regarding copyright protection for the body shape of its iconic electric guitar, the Stratocaster. Following a German court's recognition of protection within the EU, Fender has since March been expanding notices to manufacturers and retailers demanding they cease production and sales of targeted models. This is the first time a notice to Yamaha, the world's largest musical instrument maker, has come to light. Yamaha has not disclosed which models were named, but says it is reviewing the notice and considering its response. In a statement, Fender said protecting its iconic designs is part of its duty to safeguard its brand and heritage, and expressed its commitment to continuing constructive dialogue with industry partners.